FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4306411229> ?p ?o ?g. }

• W4306411229 endingPage "e056801" @default.
• W4306411229 startingPage "e056801" @default.
• W4306411229 abstract "Objective The Brazilian state of Paraná has suffered from COVID-19 effects, understanding predictors of increased mortality in health system interventions prevent hospitalisation of patients. We selected the best models to evaluate the association of death with demographic characteristics, symptoms and comorbidities based on three levels of clinical severity for COVID-19: non-hospitalised, hospitalised non-ICU ward and ICU ward. Design Cross-sectional survey using binomial mixed models. Setting COVID-19-positive cases diagnosed by reverse transcription–PCR of municipalities located in Paraná State. Patients Cases of anonymous datasets of electronic medical records from 1 April 2020 to 31 December 2020. Primary and secondary outcome measures The best prediction factors were chosen based on criteria after a stepwise analysis using multicollinearity measure, lower Akaike information criterion and goodness-of-fit χ 2 tests from univariate to multivariate contexts. Results Male sex was associated with increased mortality among non-hospitalised patients (OR 1.76, 95% CI 1.47 to 2.11) and non-ICU patients (OR 1.22, 95% CI 1.05 to 1.43) for symptoms and for comorbidities (OR 1.89, 95% CI 1.59 to 2.25, and OR 1.30, 95% CI 1.11 to 1.52, respectively). Higher mortality occurred in patients older than 35 years in non-hospitalised (for symptoms: OR 4.05, 95% CI 1.55 to 10.54; and for comorbidities: OR 3.00, 95% CI 1.24 to 7.27) and in hospitalised over 40 years (for symptoms: OR 2.72, 95% CI 1.08 to 6.87; and for comorbidities: OR 2.66, 95% CI 1.22 to 5.79). Dyspnoea was associated with increased mortality in non-hospitalised (OR 4.14, 95% CI 3.45 to 4.96), non-ICU (OR 2.41, 95% CI 2.04 to 2.84) and ICU (OR 1.38, 95% CI 1.10 to 1.72) patients. Neurological disorders (OR 2.16, 95% CI 1.35 to 3.46), neoplastic (OR 3.22, 95% CI 1.75 to 5.93) and kidney diseases (OR 2.13, 95% CI 1.36 to 3.35) showed the majority of increased mortality for ICU as well in the three levels of severity jointly with heart disease, diabetes and CPOD. Conclusions These findings highlight the importance of the predictor’s assessment for the implementation of public healthcare policy in response to the COVID-19 pandemic, mainly to understand how non-pharmaceutical measures could mitigate the virus impact over the population." @default.
• W4306411229 created "2022-10-17" @default.
• W4306411229 creator A5008237870 @default.
• W4306411229 creator A5012592530 @default.
• W4306411229 creator A5013047548 @default.
• W4306411229 creator A5022431002 @default.
• W4306411229 creator A5028028476 @default.
• W4306411229 creator A5032021016 @default.
• W4306411229 creator A5038135780 @default.
• W4306411229 creator A5038595101 @default.
• W4306411229 creator A5042829268 @default.
• W4306411229 creator A5045104573 @default.
• W4306411229 creator A5053969300 @default.
• W4306411229 creator A5056590283 @default.
• W4306411229 creator A5066350411 @default.
• W4306411229 creator A5069280799 @default.
• W4306411229 creator A5071769285 @default.
• W4306411229 creator A5072335040 @default.
• W4306411229 creator A5073119907 @default.
• W4306411229 creator A5078982662 @default.
• W4306411229 date "2022-10-01" @default.
• W4306411229 modified "2023-09-26" @default.
• W4306411229 title "Cross-sectional study for COVID-19-related mortality predictors in a Brazilian state-wide landscape: the role of demographic factors, symptoms and comorbidities" @default.
• W4306411229 cites W1995113307 @default.
• W4306411229 cites W2414448355 @default.
• W4306411229 cites W2883056653 @default.
• W4306411229 cites W2951488535 @default.
• W4306411229 cites W3004318991 @default.
• W4306411229 cites W3004442407 @default.
• W4306411229 cites W3008090866 @default.
• W4306411229 cites W3008827533 @default.
• W4306411229 cites W3009885589 @default.
• W4306411229 cites W3010466793 @default.
• W4306411229 cites W3011605790 @default.
• W4306411229 cites W3015552915 @default.
• W4306411229 cites W3016170074 @default.
• W4306411229 cites W3016388920 @default.
• W4306411229 cites W3016523961 @default.
• W4306411229 cites W3025922788 @default.
• W4306411229 cites W3033884134 @default.
• W4306411229 cites W3038328918 @default.
• W4306411229 cites W3040352829 @default.
• W4306411229 cites W3042607231 @default.
• W4306411229 cites W3042862995 @default.
• W4306411229 cites W3043040397 @default.
• W4306411229 cites W3043773740 @default.
• W4306411229 cites W3046496943 @default.
• W4306411229 cites W3082988742 @default.
• W4306411229 cites W3086755607 @default.
• W4306411229 cites W3087030846 @default.
• W4306411229 cites W3087645851 @default.
• W4306411229 cites W3092284030 @default.
• W4306411229 cites W3100073691 @default.
• W4306411229 cites W3111021405 @default.
• W4306411229 cites W3112600999 @default.
• W4306411229 cites W3123158463 @default.
• W4306411229 cites W3132886890 @default.
• W4306411229 doi "https://doi.org/10.1136/bmjopen-2021-056801" @default.
• W4306411229 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36253047" @default.
• W4306411229 hasPublicationYear "2022" @default.
• W4306411229 type Work @default.
• W4306411229 citedByCount "0" @default.
• W4306411229 crossrefType "journal-article" @default.
• W4306411229 hasAuthorship W4306411229A5008237870 @default.
• W4306411229 hasAuthorship W4306411229A5012592530 @default.
• W4306411229 hasAuthorship W4306411229A5013047548 @default.
• W4306411229 hasAuthorship W4306411229A5022431002 @default.
• W4306411229 hasAuthorship W4306411229A5028028476 @default.
• W4306411229 hasAuthorship W4306411229A5032021016 @default.
• W4306411229 hasAuthorship W4306411229A5038135780 @default.
• W4306411229 hasAuthorship W4306411229A5038595101 @default.
• W4306411229 hasAuthorship W4306411229A5042829268 @default.
• W4306411229 hasAuthorship W4306411229A5045104573 @default.
• W4306411229 hasAuthorship W4306411229A5053969300 @default.
• W4306411229 hasAuthorship W4306411229A5056590283 @default.
• W4306411229 hasAuthorship W4306411229A5066350411 @default.
• W4306411229 hasAuthorship W4306411229A5069280799 @default.
• W4306411229 hasAuthorship W4306411229A5071769285 @default.
• W4306411229 hasAuthorship W4306411229A5072335040 @default.
• W4306411229 hasAuthorship W4306411229A5073119907 @default.
• W4306411229 hasAuthorship W4306411229A5078982662 @default.
• W4306411229 hasBestOaLocation W43064112291 @default.
• W4306411229 hasConcept C105795698 @default.
• W4306411229 hasConcept C126322002 @default.
• W4306411229 hasConcept C126674687 @default.
• W4306411229 hasConcept C142052008 @default.
• W4306411229 hasConcept C142724271 @default.
• W4306411229 hasConcept C144024400 @default.
• W4306411229 hasConcept C144301174 @default.
• W4306411229 hasConcept C149923435 @default.
• W4306411229 hasConcept C156957248 @default.
• W4306411229 hasConcept C161584116 @default.
• W4306411229 hasConcept C199163554 @default.
• W4306411229 hasConcept C2779159551 @default.
• W4306411229 hasConcept C33923547 @default.
• W4306411229 hasConcept C38180746 @default.
• W4306411229 hasConcept C71924100 @default.
• W4306411229 hasConceptScore W4306411229C105795698 @default.

• next